NCT06288529Completed
EFFECT SGLT2 INHIBITORS ON CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY
PROTECTIVE EFFECT OF SGLT2 INHIBITORS ON POST-CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY IN DIABETIC AND CKD PATIENTS
Source: ClinicalTrials.gov · Last updated 1 Mar 2024
Brief summary (registry, in English)
Chronic kidney disease and type 2 diabetes mellitus patients are with in high-risk patients in coronary arterial diseases and increasing number of coronary angiography and coronary interventional procedures have been performed in these population. As well as the risk factors have been identified by many studies preventive measures are lacking. In our study we found that SGLT2 inhibitors are beneficial in terms of reducing contrast media induced acute kidney injury in both diabetic and CKD patients.This is one of the leading studies in the literature pointing that SGLT2 inhibitors may have a potentially beneficial role in reducing or preventing the development of PC-AKI.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 975 (actual)
- First submitted
- 23 Feb 2024
- Start date
- Jul 2023
- Primary completion date
- Dec 2023
- Lead sponsor
- University of Health Sciences Balikesir Hospital Eduation and Research
- Diseases
- Chronic kidney disease
- NCT number
- NCT06288529
What you commit to
- Study type: Observational
- Participants enrolled: 975
- From Jul 2023 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Patients with acute myocardial infarction, acute renal injury, history of kidney transplantation, severe heart failure (HF, New York Heart Association IV), malignancy, also patients who received other PC-AKI preventive medications like as N-acetylcysteine, sodium bicarbonate, or incomplete medical records were excluded from the analyses.
Who the study is looking for
- Patients who underwent coronary artery imaging or percutaneous coronary intervention procedures using contrast media
- Patient ages were between 18 and 75 years
- Estimated glomerular filtration rates (eGFRs) between 25 and 115
Age in the registry: 18 years to 75 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Health Sciences Balikesir Education and Research Hospital Coordinator of this site? Confirm its status | Balıkesir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.